ABSTRACT
No abstract available.
Subject(s)
Female , Abortion, Induced , Patient Acceptance of Health CareABSTRACT
No abstract available.
Subject(s)
Female , Abortion, Induced , Patient Acceptance of Health CareABSTRACT
We describe the use of gold-coating expandable urethral stents implanted into 3 patients with urinary obstruction due to recurrent urethral stricture(one case) and inoperable benign prostatic hypertrophy(two cases) respectively. The stent formed from stainless steel in the form of a cylindrical zigzag pattern and coated with 24 carat gold was inserted via delivering device using fluoroscopy control under heal anesthesia. During 6 months follow-up. the stents remained in situ and there were no urinary incontinence or other complication. The maximum flow rate were 24ml/sec in case of urethral stricture and 20ml/sec in BPH. These patients were satisfied with the procedure which provided a quiet safe and effective alternative to conventional surgical treatment.
Subject(s)
Humans , Anesthesia , Fluoroscopy , Follow-Up Studies , Stainless Steel , Stents , Urethral Obstruction , Urethral Stricture , Urinary IncontinenceABSTRACT
A total or 56 patients who underwent TUR-BT for superficial (stages O and A) bladder tumors received various chemoprophylactic treatment to prevent recurrence. 16 patients underwent resection only (Group I). Of the 56 patients treated with chemoprophylactic agents 18 patients were given thio-tepa at weekly interval for 8 weeks (Group 2). 20 patients were given adriamycin. weekly one time for 6 weeks (Group 3). 16 patients were given mitomycin C, weekly one time for 8 weeks (Group 4). All chemoprophylactic groups were followed by monthly one time for 1 year and the dosages of the used agents (thio-tepa, adriamycin and mitomycin C) were 60 mg/l dosage, 50 mg/l dosage and 30 ml/l dosage, respectively. During follow-up period (mean duration; 19.8-25. 2 months), 1umor recurred 56.2 % of group 1 patients, 27.7 % of group 2 patients, 25.0% of group 3 patients, 18.9 % of group 4 patients and 22.2% of total patients. Therefore three drugs were effective to decrease the recurrence rate of superficial bladder tumor and no significant differences in recurrence rate were noticed among drugs. Toxicity of the three agents were negligibly minimal except 2 patients who developed severe gross hematuria after adriamycin instillation.